Tri-orthoalkylphenyl Phosphine Ligands for Stereoretentive Csp3 Cross-Coupling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The synthesis of stereochemically complex Csp3-rich small molecules remains a highly customized, slow, and specialist-dependent process, hindering access to their substantial functional potential due to challenges in achieving stereospecific carbon-carbon bond formation with high stereocontrol.

Innovation Solution

Development of new phosphine ligands, such as tri(2-benzyl-phenyl)phosphine, that selectively shield positions above or below the Pd(II) complex, enabling stereoretentive Csp3 cross-couplings by inhibiting stereoinvertive transmetalation pathways, thereby facilitating the Lego-like synthesis of complex Csp3-rich natural products and their stereoisomers from off-the-shelf chiral building blocks.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If traditional Csp3 cross-coupling methods are used, then carbon-carbon bond formation can be achieved, but stereoisomer mixtures are produced due to competing stereodivergent pathways

Engineering Contradiction:
ImprovestereocontrolVSAvoidstereoisomer purity
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The phosphine ligand introduces localized steric shielding at specific positions around the Pd(II) complex, creating an asymmetric environment that differentiates between the two enantiotopic faces. This local steric differentiation selectively blocks one transmetalation pathway while allowing the other, achieving high stereoselectivity without requiring complete structural asymmetry throughout the entire complex.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The invention employs chiral phosphine ligands with asymmetric structures that create diastereomeric transition states for the two competing transmetalation pathways. The asymmetric ligand environment makes one pathway energetically favorable over the other, leading to preferential formation of one stereoisomer. The ortho-substituents on the phosphine create inherent asymmetry that directs the stereochemical outcome.

Inventive Principle:
Principle #4Asymmetry

2Manufacturing precision

If highly customized synthetic routes are used, then complex Csp3-rich molecules can be synthesized, but the process becomes slow and specialist-dependent

Engineering Contradiction:
Improvemolecular complexityVSAvoidsynthesis speed
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The phosphine ligand system provides a universal platform for Csp3 cross-coupling reactions that can be applied to diverse substrates and building blocks. The same catalytic system with the novel phosphine ligand can handle various organoboronate reagents and electrophiles, enabling a generalized approach that replaces multiple specialized routes. This universality accelerates synthesis by eliminating the need to develop custom conditions for each transformation.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The invention modifies key reaction parameters through the phosphine ligand's electronic and steric properties, optimizing the catalytic cycle for high efficiency. The ligand's electronic tuning affects oxidative addition rates, transmetalation efficiency, and reductive elimination kinetics, creating a parameter regime where stereoretentive pathways are accelerated relative to competing pathways. This parameter optimization enables rapid, high-yielding transformations.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If standard phosphine ligands are used, then Pd(II) complex catalysis can proceed, but stereoinvertive transmetalation cannot be selectively inhibited

Engineering Contradiction:
Improvereaction efficiencyVSAvoidstereoretention
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The phosphine ligand introduces localized steric shielding at specific positions around the Pd(II) complex, creating an asymmetric environment that differentiates between the two enantiotopic faces. This local steric differentiation selectively blocks one transmetalation pathway while allowing the other, achieving high stereoselectivity without requiring complete structural asymmetry throughout the entire complex.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The phosphine ligand acts as an intermediary that mediates the interaction between the organoboronate reagent and the Pd(II) complex. By positioning bulky ortho-substituents, the ligand sterically blocks the approach of the reagent to one face of the complex, forcing transmetalation to occur through the less hindered pathway. This intermediary steric barrier selectively channels the reaction through the stereoretentive pathway.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for near-perfect site- and stereoretention in Csp3 cross-coupling reactions, significantly improving the efficiency and flexibility of small molecule synthesis by enabling the simple, automated assembly of complex Csp3-rich molecules with high enantiospecificity and branched to linear product ratios.

Implementation Method 1

phosphine ligands which selectively shield these positions would promote stereoretentive Csp3 cross-couplings

Methodology Applied
Scientific EffectSteric hindrance:

Implementation Method 2

cross-coupling of unactivated secondary Csp3 boronic acids with near perfect site- and stereoretention

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentUS10370393B2Stereoretentive cross-coupling of boronic acids
Publication Date: 2019.08.06 THE BOARD OF TRUSTEES OF THE UNIV OF ILLINOIS
  • US10370393B2 patent drawing
  • US10370393B2 patent drawing
  • US10370393B2 patent drawing

AI summary

The present disclosure provides tri-orthoalkylphenyl phosphine catalysts of formula Iwherein A is CH2, C═O, or NRA; R1 is aryl, heteroaryl, isopropyl, tert-butyl, cycloalkyl, or heterocycloalkyl, wherein aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted; R2 is H, (C1-C8)alkyl, (C1-C8)alkoxy, N(RA)2, or an electron withdrawing group; and each RA is independently H or (C1-C8)alkyl; that are tuned electrically and sterically.